The science of skin aging is evolving rapidly — and for women navigating the skin changes that come with menopause and beyond, evidence-based skincare represents a fundamentally different approach: working with your skin's biology rather than against it.
Unlike harsh exfoliants or retinoids that disrupt the skin barrier to force renewal, targeted active ingredients are messenger molecules that signal your own cells to produce more collagen, elastin, and protective proteins. The approach is gentle, evidence-based, and particularly suited to the thinner, more reactive skin that characterizes the post-menopausal years.
Managing the Most Common Melasma Pattern Across the Central Face
Centrofacial melasma is the most prevalent pattern, accounting for 50-80% of all melasma cases depending on the population studied. It presents as symmetric hyperpigmentation across the central face — forehead, cheeks, bridge of nose, upper lip, and chin — following the distribution of the highest melanocyte and estrogen receptor density on the face. This pattern is distinguished from malar melasma (cheeks only) and mandibular melasma (jawline) by its involvement of multiple central facial zones simultaneously. The centrofacial pattern is typically the most treatment-resistant because it involves the largest surface area, the deepest pigment (dermal component is most prominent in centrofacial melasma), and the most hormonally responsive melanocytes. Women with centrofacial melasma often describe the patches as a mask that covers the middle of their face — which is precisely why melasma was historically called chloasma or 'the mask of pregnancy.'[1]
The zone-adapted treatment approach recognizes that different areas within centrofacial melasma have different tolerances and respond at different rates. The forehead tolerates the most aggressive treatment and often responds fastest — azelaic acid 20% plus retinol 0.5% can be used here when the same concentrations would irritate the upper lip. The cheeks represent the middle ground — standard concentrations (azelaic acid 15%, retinol 0.25%) work well. The nose bridge has thinner skin over cartilage and responds to lower concentrations — azelaic acid 10-15% is usually sufficient. The upper lip is the most sensitive zone and requires the gentlest approach — tranexamic acid 3% and niacinamide 5% only, with azelaic acid added at 10% only after 4-6 weeks of tolerance building. The chin often has the most variable response due to hormonal acne influences in the same area during perimenopause.
Clinical research confirms that the centrofacial-specific protocol that addresses all zones simultaneously: Morning — cleanse, tranexamic acid 5% serum to full face (3% on upper lip), niacinamide 5% moisturizer to full face, tinted mineral SPF 50 with iron oxide applied generously in two layers with particular attention to the central face. Evening rotation — Monday/Thursday: azelaic acid 15% to cheeks, forehead, chin, nose (10% on upper lip), ceramide moisturizer. Tuesday/Friday: retinol 0.25% using sandwich method on forehead and cheeks only, ceramide moisturizer on full face. Wednesday/Saturday: niacinamide 10% serum to full face, ceramide moisturizer. Sunday: recovery night — ceramide moisturizer only. This rotation provides 6 active treatment nights per week through alternating mechanisms, with one recovery night to prevent cumulative irritation.
Expected treatment trajectory for centrofacial melasma: this pattern takes longer to treat than malar or mandibular because the surface area is larger and the dermal component is typically more prominent. Initial improvement at 8-12 weeks as the superficial epidermal pigment begins to clear. The nose bridge and cheeks usually lighten first because they receive the most consistent product application. The forehead shows slower initial improvement despite tolerating more aggressive treatment because it has the most extensive dermal pigment component. The upper lip shows the slowest visible improvement because it receives the gentlest treatment — but by 16-20 weeks, most women notice that the lip shadow has softened significantly. Maximum improvement from topical therapy alone is typically reached at 24-32 weeks, with the centrofacial mask transitioning from a prominent, mask-like appearance to diffuse, mild unevenness that is easily concealed with tinted SPF alone. Continued maintenance therapy is essential — centrofacial melasma has the highest relapse rate among the three patterns, requiring indefinite niacinamide plus tinted SPF at minimum.
Your skin's capacity to repair and rebuild doesn't end at menopause — it just needs the right signals.
— Dr. Rachel Holbrook, Board-Certified Dermatologist
What This Means For Your Skin
If you've tried retinol and experienced irritation, or if your skin has become more sensitive with age, there is a path forward. The clinical evidence shows consistent, measurable improvement in wrinkle depth, skin firmness, and elasticity — without the adaptation period, peeling, or photosensitivity that other anti-aging actives demand.
Your skin's capacity to repair and rebuild doesn't diminish — it just needs the right support. A well-formulated skincare routine applied consistently for 8-12 weeks allows sufficient time for new collagen fibers to mature and integrate into your skin's existing matrix.
The science is clear. The evidence is consistent. The results are measurable.
What happens next is up to you.